REGADENOSON and CHEST PAIN

Overview

CHEST PAIN is the #10 most commonly reported adverse reaction for REGADENOSON, manufactured by Astellas Pharma US, Inc.. There are 230 FDA adverse event reports linking REGADENOSON to CHEST PAIN. This represents approximately 2.7% of all 8,610 adverse event reports for this drug.

Patients taking REGADENOSON who experience chest pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CHEST PAIN is a less commonly reported adverse event for REGADENOSON, but still significant enough to appear in the safety profile.

Other Side Effects of REGADENOSON

In addition to chest pain, the following adverse reactions have been reported for REGADENOSON:

• NAUSEA — 509 reports
• DYSPNOEA — 408 reports
• INJECTION SITE EXTRAVASATION — 361 reports
• VOMITING — 357 reports
• HEADACHE — 315 reports
• HYPOTENSION — 312 reports
• CARDIAC ARREST — 283 reports
• DIZZINESS — 272 reports
• SEIZURE — 251 reports
• BLOOD PRESSURE DECREASED — 207 reports

Other Drugs Associated with CHEST PAIN

The following drugs have also been linked to chest pain in FDA adverse event reports:

Does REGADENOSON cause CHEST PAIN?

CHEST PAIN has been reported as an adverse event in 230 FDA reports for REGADENOSON. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CHEST PAIN with REGADENOSON?

CHEST PAIN accounts for approximately 2.7% of all adverse event reports for REGADENOSON, making it a notable side effect.

What should I do if I experience CHEST PAIN while taking REGADENOSON?

If you experience chest pain while taking REGADENOSON, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages